Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration

• Jenna M. Faircloth,
• Neelam D. Bhatt,
• Corey A. Chartan,
• Ryan D. Coleman,
• Natalie Villafranco,
• Fadel E. Ruiz,
• Raysa Morales-Demori,
• Elise Whalen,
• Erin Ely,
• Rozmeen Fombin,
• Nidhy P. Varghese

Affiliations

Jenna M. Faircloth

Department of Pharmacy, Texas Children’s Hospital, Houston, TX, United States

Neelam D. Bhatt

Department of Pharmacy, Texas Children’s Hospital, Houston, TX, United States

Corey A. Chartan

Department of Pediatrics, Division of Critical Care and Pulmonology, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, United States

Ryan D. Coleman

Department of Pediatrics, Division of Critical Care and Pulmonology, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, United States

Natalie Villafranco

Department of Pediatrics, Division of Pulmonology, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, United States

Fadel E. Ruiz

Department of Pediatrics, Division of Pulmonology, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, United States

Raysa Morales-Demori

Department of Pediatrics, Division of Critical Care, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, United States

Elise Whalen

Department of Pulmonary Medicine, Texas Children’s Hospital, Houston, TX, United States

Erin Ely

Department of Pulmonary Medicine, Texas Children’s Hospital, Houston, TX, United States

Rozmeen Fombin

Department of Pulmonary Medicine, Texas Children’s Hospital, Houston, TX, United States

Nidhy P. Varghese

Department of Pediatrics, Division of Pulmonology, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, United States